Lensar (LNSR) Depreciation & Amortization (CF) (2019 - 2026)
Lensar (LNSR) reported Depreciation & Amortization (CF) of $904000.0 for Q1 2026, up 7.11% year-over-year from $844000.0 in Q1 2025, and down 4.24% quarter-over-quarter from $944000.0 in Q4 2025.
Lensar (LNSR) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $904000.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $904000.0, up 7.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (up 15.29% YoY), and the FY2025 annual result was $3.6 million, up 20.94% from the prior year.
- Depreciation & Amortization (CF) retreated to $904000.0 in Q1 2026 per LNSR's latest filing, from $944000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $944000.0 in Q4 2025 and troughed at $541000.0 in Q1 2022.
- A 5-year average of $713058.8 and a median of $651000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 66.37% in 2022, then rose 1.93% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $577000.0 in 2022, then advanced by 12.82% to $651000.0 in 2023, then jumped by 34.25% to $874000.0 in 2024, then increased by 8.01% to $944000.0 in 2025, then dropped by 4.24% to $904000.0 in 2026.
- Business Quant data shows LNSR's Depreciation & Amortization (CF) at $904000.0 in Q1 2026, $944000.0 in Q4 2025, and $928000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | 904,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 904,000.00 |
| Mar 31, 2026 | 904,000.00 |
| Dec 31, 2025 | 944,000.00 |
| Dec 31, 2025 | 944,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Dec 31, 2024 | 874,000.00 |
| Dec 31, 2024 | 874,000.00 |
| Sep 30, 2024 | 774,000.00 |
| Sep 30, 2024 | 774,000.00 |
| Jun 30, 2024 | 666,000.00 |
| Jun 30, 2024 | 666,000.00 |
| Mar 31, 2024 | 647,000.00 |
| Mar 31, 2024 | 647,000.00 |
| Dec 31, 2023 | 651,000.00 |
| Dec 31, 2023 | 651,000.00 |